Track Multiple Sclerosis Symptoms Between Neurology Visits

What to track when you have MS

These are the symptoms that carry the most information in MS, both for spotting a relapse and for describing the slow background changes between them.

• Fatigue, consistently the most disabling MS symptom and the one most likely to be underestimated at appointments, so severity logged daily shows its real weight.
• Vision changes, blurring, a washed-out patch or loss of color in one eye can mean optic neuritis, which needs prompt review rather than a wait-and-see.
• Eye pain and redness, pain on moving the eye often precedes visual loss in optic neuritis by a day or two, and the date matters.
• Numbness or tingling, new sensory bands, patches or an electric feeling on bending the neck are common first signs of a new lesion.
• Muscle weakness, recording which limb and how long it lasts is what distinguishes a relapse from end-of-day fatigue weakness.
• Muscle spasm, spasticity and night cramps track with disease burden and with how well baclofen, tizanidine or gabapentin are working.
• Dizziness or vertigo, brainstem lesions produce true spinning that lasts days, worth separating from lightheadedness on standing.
• Brain fog, slowed processing speed is a genuine MS symptom, not stress, and it often worsens in parallel with fatigue.
• Memory lapses, logging when they cluster helps distinguish cognitive relapse-related change from sleep debt or medication effects.
• Bladder symptoms, urgency, frequency and leakage are common and treatable, and they raise the question of urinary infection, which can drive a pseudo-relapse.
• Heat intolerance, the Uhthoff phenomenon, where a rise in core temperature temporarily slows conduction in demyelinated nerves and old symptoms resurface.
• Reduced daily function, the practical measure your neurologist is really asking about: what you stopped being able to do, and when.

Triggers and relievers worth logging in MS

Lifestyle factors go on the same daily timeline as symptoms, so you can see what sat alongside a bad week rather than guessing.

• Heat exposure, hot weather, hot baths, saunas and even a fever will temporarily unmask old symptoms, and logging it is the fastest way to tell a pseudo-relapse from a true one.
• Physical activity, exercise raises core temperature and can cause a short-lived flare, but regular aerobic and resistance work reliably reduces MS fatigue over weeks.
• Physical therapy, logging sessions lets you see whether a gait or spasticity program is actually changing weakness and spasm scores over a couple of months.
• Rest and pacing, energy management is the intervention with the best evidence for MS fatigue, and it only shows its effect when you can see the days you paced against the days you did not.
• Poor sleep, nocturia, spasms and restless legs fragment sleep in MS, and the next-day fatigue and brain fog are often blamed on the disease instead.
• Stress, stress does not create lesions on demand, but it reliably amplifies fatigue and cognitive symptoms, and it helps to see that pattern in your own data.
• Daily medications, disease-modifying therapy, symptomatic drugs and steroid courses all have timelines, and side effects like flu-like symptoms after interferon or flushing after dimethyl fumarate are easier to interpret when dated.

Why one bad week tells you nothing

The decisive judgment in MS is whether new or worsening neurological symptoms lasted more than 24 hours, in the absence of infection or fever, and appeared at least 30 days after the last episode. That is the definition of a relapse, and it is the threshold for steroids and for reconsidering your disease-modifying therapy. A pseudo-relapse looks identical from the inside: old symptoms return because you are hot, run down, or brewing a urinary infection, and they settle once the temperature or the infection does. Only the timeline separates them, and only if you wrote it down at the time.

Progressive change is a different problem. Slow decline in walking distance, bladder control or processing speed happens too gradually to notice month to month. Most people need six to twelve months of consistent logging before the yearly chart shows a genuine slope rather than noise, and about four to eight weeks before day-level patterns like heat sensitivity or pacing effects become obvious.

Preparing for your neurology appointment

Neurology follow-up in MS is often six-monthly or annual, sometimes with an MS nurse specialist in between. The questions are predictable: have you had any new symptoms since we last met, how long did they last, were you unwell or feverish at the time, how is your walking compared to last year, how is the fatigue, are you taking the DMT and tolerating it. Answering those from memory across six months is close to impossible.

A doctor-ready PDF from Trace Health puts dated entries in front of them: the week in March when vision blurred for four days, the fact that it followed a fever, the steady rise in fatigue severity since the summer. That is the material a neurologist uses when deciding whether to escalate from an injectable or oral agent to a higher-efficacy therapy such as an anti-CD20 infusion, or whether to request an interval MRI. Trace Health does not diagnose or treat anything, it just makes sure the history in the room is accurate.

Frequently asked questions

How do I tell a real MS relapse from a pseudo-relapse?

The clinical rule is duration and context. A true relapse means new or clearly worsening neurological symptoms lasting more than 24 hours, without fever, infection or overheating to explain them, at least a month after any previous episode. A pseudo-relapse is old symptoms resurfacing because of heat, exertion, a urinary or chest infection, or exhaustion, and it settles as those resolve. Logging [[s:heat_intolerance|heat intolerance]] and [[l:heat_exposure|heat exposure]] alongside symptoms makes the difference visible. Contact your MS team either way if you are unsure.

How long do I need to track before MS patterns show up?

Short-term patterns come quickly. Four to eight weeks of daily logging is usually enough to show how strongly your symptoms track with heat, poor sleep and overexertion, and whether pacing genuinely helps your fatigue. Relapse patterns and progressive change need longer. Six to twelve months gives your neurologist a real picture of how often episodes occur, how long they last, and whether your walking, bladder or cognition is drifting rather than fluctuating. The yearly chart is where slow change becomes undeniable.

Can I share my MS log with my neurologist or MS nurse?

Yes. Trace Health exports a doctor-ready PDF covering whatever date range you choose, so you can bring the six months since your last review or just the fortnight around a suspected relapse. It shows dated symptom entries with mild, moderate or severe severity, alongside the lifestyle factors logged on the same days. Most clinicians can scan it in under a minute, which is faster and more accurate than reconstructing six months of events from memory in a twenty-minute appointment.

Is my MS data private, given it could affect insurance or work?

Your data stays on your iPhone by default. There is no account to create, no email address to hand over, and nothing uploaded to a Trace Health server. If you turn on iCloud sync it goes to your own private iCloud, not to us. Nothing is shared with an employer, an insurer or anyone else unless you choose to export a PDF and send it yourself. For a condition where people are careful about who knows what and when, that matters.

Does tracking help if I have progressive MS rather than relapsing MS?

It arguably helps more. In primary or secondary progressive MS there are fewer discrete relapses to report, so the clinical question becomes rate of change: is walking distance shrinking, is [[s:fatigue|fatigue]] rising, are [[s:incontinence|bladder symptoms]] or [[s:brain_fog|brain fog]] worse than a year ago. Those shifts are too slow to feel. Monthly and yearly charts of severity give your neurologist an objective slope to look at, which informs decisions about symptomatic treatment, rehabilitation referral and therapies licensed for progressive disease.